Kenichiro Nishida
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Associations between computed tomography features and obstructive lung diseases: The NOVELTY-CT substudy.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: March 04, 2026
Sequential Use of Systemic Therapy With Locoregional Therapy for Hepatocellular Carcinoma in Japan: Analyses of Real-World Data Based on a Health Claims Database.
Journal: Cancer medicine
Published: October 09, 2025
Exacerbation and cardiopulmonary risk after prompt initiation of single-inhaler budesonide /glycopyrrolate/formoterol fumarate following COPD exacerbations: Insights from MITOS EROS (Japan) study.
Journal: Respiratory investigation
Published: August 01, 2025
Real-world effectiveness of budesonide/glycopyrronium/formoterol fumarate metered dose inhaler on symptoms and quality of life in patients with COPD: EBISU study.
Journal: Respiratory investigation
Published: March 18, 2025
Increased Risk of Severe Cardiovascular Events Following Exacerbations of Chronic Obstructive Pulmonary Disease: Results of the EXACOS-CV Study in Japan.
Journal: Advances in therapy
Published: April 18, 2024
Real-world evidence of systemic treatment practices for biliary tract cancer in Japan: Results of a database study.
Journal: Journal of hepato-biliary-pancreatic sciences
Published: October 11, 2023
A Retrospective Claims Database Study to Clarify Disease Burden of Severe Asthma Patients with Type 2 High or Low Inflammation.
Journal: Journal of asthma and allergy
Published: July 12, 2022
Rationale and design of the EMPA-ELDERLY trial: a randomised, double-blind, placebo-controlled, 52-week clinical trial of the efficacy and safety of the sodium-glucose cotransporter-2 inhibitor empagliflozin in elderly Japanese patients with type 2 diabetes.
Journal: BMJ open
Published: April 08, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026